Sajid Jabbar Hasan (1), Sarah Hamed Abd Alsaheb (2)
Background: In Iraq, breast cancer poses an unprecedented public health risk, with rising incidence rates coupled with complex treatment barriers impacting patients' outcomes. The objective of this study was to explore the state of breast cancer in Iraq, identifying influences on treatment outcomes and on patients´ access to breast cancer care in Iraq.
Methods: From January 2023 to December 2024, we conducted a cross-sectional study at many hospitals in Iraq, including site visits, screening medical records of 847 breast cancer patients´ medical records, studying their treatment pathways and treatment outcomes. Data collected comprised of demographic characteristics, clinical presentations and staging of the cancer, treatment types, and barriers to treatment. We used SPSS version 28.0 for the statistical analyses.
Results: The mean age at diagnosis was 48.2 years (SD ± 11.7). Late-stage presentation were common: 62.4% of patients were staged diagnosed at level III or IV. The overall 5-year survival was 58.3%. Reported barriers to treatment included: financial costs (73.2%), geographic barriers (45.8%), and medication availability (51.7%). We found a statistically significant difference between urban and rural patient outcomes (p<0.001). Multidisciplinary patient care was available for only 34.7% of patients.
Conclusions: Breast cancer outcomes in Iraq are limited due to late presentations, the limited resources, and systemic barriers to treatment. There is an urgent need to implement interventions that improve early detection of breast cancer; increase patients' access to treatment, and strengthen the public health infrastructure to address this important and growing public health issue.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
2. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in Asia. Asian Pac J Cancer Prev. 2016;17(S3):47-52.
3. Al-Hashimi MM, Wang XJ. Breast cancer in Iraq, incidence trends from 2000-2009. Asian Pac J Cancer Prev. 2014;15(1):281-286.
4. Alwan NA, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. Comparative study on the clinicopathological profiles of breast cancer among Iraqi and British patients. Open Public Health J. 2018;11(1):177-191.
5. Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012;17(6):775-782.
6. Azaiza F, Cohen M, Awad M, Daoud F. Factors associated with low screening for breast cancer in the Palestinian Authority: relations of availability, environmental barriers, and cancer-related fatalism. Cancer. 2010;116(19):4646-4655.
7. Lafta R, Aflouk NA, Dhiaa S, Lyles E, Burnham G, Roberts L. Needs assessment for cancer diagnosis and treatment in Iraq. J Glob Oncol. 2018;4:1-8.
8. Hassan ZK, Taher GM. Breast cancer and some epidemiological factors in Iraqi patients in Baghdad. J Contemp Med Sci. 2018;4(2):88-92.
9. Iraq Cancer Registry. Annual report 2020. Baghdad: Iraqi Cancer Board; 2021.
10. Alwan NA, Tawfeeq FN, Maallah MH. Demographic and clinical profiles of female breast cancer patients in Iraq. J Contemp Med Sci. 2019;5(1):14-19.
11. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023-1075.
12. Al-Naggar RA, Osman MT, Anwar MM, Bobryshev YV. Breast cancer in Iraq: an epidemiological study. Asian Pac J Cancer Prev. 2016;17(4):1999-2003.
13. Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, et al. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer. 2008;8:278.
14. Al-Hashimi MM, Wang XJ. Early detection of breast cancer in Iraq: knowledge, attitudes, and practices of Iraqi women. Asian Pac J Cancer Prev. 2014;15(11):4521-4526.
15. Abdel-Razeq H, Attiga F, Mansour A. Cancer care in Jordan. Hematol Oncol Stem Cell Ther. 2015;8(2):64-70.
16. Donnelly TT, Al Khater AH, Al-Bader SB, Al Kuwari MG, Al-Meer N, Malik M, et al. Breast cancer screening among Arabic women living in the State of Qatar: awareness, knowledge, and participation in screening activities. Avicenna J Med. 2013;3(4):77-82.
17. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718.
18. Qureshi NA, Nair SC, Abdelgadir MH, Shah JN, Shehri AM, Memish ZA. The multi-disciplinary team approach to cancer management: does it work? J Fam Community Med. 2010;17(2):67-72.
19. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics. Do they work? Cancer. 1997;79(12):2380-2384.
20. Alwan N, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. The economic burden of breast cancer treatment in Iraq. J Glob Oncol. 2020;6:1535-1545.
21. Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608-1614.
22. Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist. 2015;20(9):1092-1098.
23. Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Stevan M. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7:311-323.
24. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020;25(6):e936-e945.
25. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267.
26. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194-1220.
27. Al-Azri M, Al-Awisi H, Al-Moundhri M. Coping with a diagnosis of breast cancer-literature review and implications for developing countries. Breast J. 2009;15(6):615-622.
28. Silbermann M, Pitsillides B, Al-Alfi N, Omran S, Al-Jabri K, Elshamy K, et al. Multidisciplinary care team for cancer patients and its implementation in several Middle Eastern countries. Ann Oncol. 2013;24(suppl 7):vii41-vii47.
29. Silbermann M, Arnaout M, Daher M, Nestoros S, Pitsillides B, Charalambous H, et al. Palliative cancer care in Middle Eastern countries: accomplishments and challenges. Ann Oncol. 2012;23(suppl 3):15-28.
30. Vanderpuye V, Grover S, Hammad N, PoojaDdv D, Simonds H, Olopade F, et al. An update on the management of breast cancer in Africa. Infect Agent Cancer. 2017;12:13.
31. Akala FA, El-Saharty S. Public-health challenges in the Middle East and North Africa. Lancet. 2006;367(9515):961-964.
32. Elshami M, Elshami A, Alshorbassi N, Alkhatib M, Ismail I, Abu-Nemer K, et al. Hematological malignancies in the Gaza Strip, Palestine: a retrospective study. Lancet. 2020;396(suppl 1):S6.
33. Silbermann M, Pitsillides B, Al-Alfi N, Omran S, Al-Jabri K, Elshamy K, et al. Multidisciplinary care team for cancer patients and its implementation in several Middle Eastern countries. Ann Oncol. 2013;24(suppl 7):vii41-vii47.
34. Saleh K, Vermund SH, Wood F. Cancer in the Arab world: the next challenge for public health. East Mediterr Health J. 2007;13(5):1090-1097.
35. Ministry of Health Iraq. National cancer control strategy 2020-2025. Baghdad: MOH Iraq; 2020.
36. Alwan NA, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. Comparative study on the clinicopathological profiles of breast cancer among Iraqi and British patients. Open Public Health J. 2018;11(1):177-191.
37. Rashid SF, Kader M, Perera NK, Sharma A, Khalil MI, Nahar Q, et al. Breast cancer care in Bangladesh: a situation analysis. J Cancer Policy. 2019;19:100186.
38. Alwan NA, Tawfeeq FN, Maallah MH. Demographic and clinical profiles of female breast cancer patients in Iraq. J Contemp Med Sci. 2019;5(1):14-19.
39. Hassan ZK, Taher GM. Breast cancer and some epidemiological factors in Iraqi patients in Baghdad. J Contemp Med Sci. 2018;4(2):88-92.
40. Iraq Cancer Registry. Annual report 2019. Baghdad: Iraqi Cancer Board; 2020.
41. Alwan NA, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. The economic burden of breast cancer treatment in Iraq. J Glob Oncol. 2020;6:1535-1545.
42. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438-451.
43. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in Asia. Asian Pac J Cancer Prev. 2016;17(S3):47-52.
44. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599-1614.
45. Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, André F, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623-1649.
46. Najjar H, Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg. 2010;8(6):448-452.
47. Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012;17(6):775-782.
48. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753-758.
49. Baade PD, Turrell G, Aitken JF. Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional analysis of 10,515 women. Breast Cancer Res Treat. 2011;128(3):809-816.
50. Hébert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer. 2005;104(7):1343-1348.
51. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718.
52. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics. Do they work? Cancer. 1997;79(12):2380-2384.
53. Alwan N, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. The economic burden of breast cancer treatment in Iraq. J Glob Oncol. 2020;6:1535-1545.
54. Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80-81, 149.
55. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353(16):1673-1684.
56. Ministry of Health Iraq. Pharmaceutical sector assessment report. Baghdad: MOH Iraq; 2021.
57. Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608-1614.
58. Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330-339.
59. Akala FA, El-Saharty S. Public-health challenges in the Middle East and North Africa. Lancet. 2006;367(9515):961-964.
60. Donnelly TT, Al Khater AH, Al-Bader SB, Al Kuwari MG, Al-Meer N, Malik M, et al. Breast cancer screening among Arabic women living in the State of Qatar: awareness, knowledge, and participation in screening activities. Avicenna J Med. 2013;3(4):77-82.
61. Azaiza F, Cohen M, Awad M, Daoud F. Factors associated with low screening for breast cancer in the Palestinian Authority: relations of availability, environmental barriers, and cancer-related fatalism. Cancer. 2010;116(19):4646-4655.
62. Al-Azri M, Al-Awisi H, Al-Moundhri M. Coping with a diagnosis of breast cancer-literature review and implications for developing countries. Breast J. 2009;15(6):615-622.
63. Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163(1):83-90.
64. Friedman DB, Hoffman-Goetz L. A systematic review of readability and comprehension instruments used for print and web-based cancer information. Health Educ Behav. 2006;33(3):352-373.
65. Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412-419.
66. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2106.
67. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716.
68. Silbermann M, Pitsillides B, Al-Alfi N, Omran S, Al-Jabri K, Elshamy K, et al. Multidisciplinary care team for cancer patients and its implementation in several Middle Eastern countries. Ann Oncol. 2013;24(suppl 7):vii41-vii47.
69. Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120-4128.
70. Baade PD, Turrell G, Aitken JF. Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional analysis of 10,515 women. Breast Cancer Res Treat. 2011;128(3):809-816.
71. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023-1075.
72. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599-1614.
73. Doolittle GC, Yaezel A, Otto F, Clemens C. Hospice care using home-based telemedicine systems. J Telemed Telecare. 1998;4(1):58-59.
74. Alwan NA, Kerr D, Al-Okati D, Donnelly D, Lyons J, Al-Esmaeel F, et al. The economic burden of breast cancer treatment in Iraq. J Glob Oncol. 2020;6:1535-1545.
75. Ministry of Health Iraq. Pharmaceutical sector assessment report. Baghdad: MOH Iraq; 2021.
76. Silbermann M, Arnaout M, Daher M, Nestoros S, Pitsillides B, Charalambous H, et al. Palliative cancer care in Middle Eastern countries: accomplishments and challenges. Ann Oncol. 2012;23(suppl 3):15-28.
77. Donnelly TT, Al Khater AH, Al-Bader SB, Al Kuwari MG, Al-Meer N, Malik M, et al. Breast cancer screening among Arabic women living in the State of Qatar: awareness, knowledge, and participation in screening activities. Avicenna J Med. 2013;3(4):77-82.